Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung condition primarily affecting premature infants. It significantly impacts their growth, development, and health. Recently, in vitro models have been created, offering new insights into the causes and potential treatments for BPD. This review summarizes the current methods for creating in vitro models of BPD. It also discusses their evaluation criteria and applications in drug testing and biological research. This paper evaluates the advantages and disadvantages of different models.